Literature DB >> 2740697

Exacerbation of human cataplexy by prazosin.

M S Aldrich1, A E Rogers.   

Abstract

A middle-aged woman with narcolepsy developed a pronounced exacerbation of cataplexy within 3 days of beginning treatment for hypertension with prazosin, an alpha 1-adrenoceptor antagonist. At times, episodes of cataplexy were virtually continuous (status cataplecticus), and there was only partial amelioration with tricyclic antidepressants. Cataplexy improved when prazosin was discontinued. These findings are similar to the reported effects of prazosin on cataplexy in narcoleptic dogs; they support a role for altered alpha 1-adrenoceptor function in narcolepsy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2740697     DOI: 10.1093/sleep/12.3.254

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  6 in total

1.  Status cataplecticus precipitated by abrupt withdrawal of venlafaxine.

Authors:  Janice Wang; Harly Greenberg
Journal:  J Clin Sleep Med       Date:  2013-07-15       Impact factor: 4.062

2.  Pseudo Status Cataplecticus in Narcolepsy Type 1.

Authors:  Candace N Meinen; Kelsey M Smith; Jan-Mendelt Tillema; Suresh Kotagal
Journal:  J Clin Sleep Med       Date:  2018-09-15       Impact factor: 4.062

3.  A consensus definition of cataplexy in mouse models of narcolepsy.

Authors:  Thomas E Scammell; Jon T Willie; Christian Guilleminault; Jerome M Siegel
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

Review 4.  Narcolepsy in the older adult: epidemiology, diagnosis and management.

Authors:  Sangeeta S Chakravorty; David B Rye
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 5.  Adverse effects of alpha 1-adrenergic blocking drugs.

Authors:  S G Carruthers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

6.  Sleep, Narcolepsy, and Sodium Oxybate.

Authors:  Mortimer Mamelak
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.